Latest Kaiser Health News Stories
The controversial practice — done by just a few other states — recently cast a spotlight on some prominent doctors. Supporters say it improves performance; detractors warn it discourages taking on complex cases.
LogistiCare often shows up late, if at all, and compromises patient safety, according to a public interest firm’s lawsuit. The company says the allegations are inaccurate.
LivaNova plant in Germany is the likely source behind outbreak that has sickened more than 100 people since 2013.
Simultaneous surgeries have ignited an impassioned debate in the medical community.
Of the 528 nursing homes that graduated from special focus status before 2014 and are still operating, more than half — 52 percent — have harmed patients or operated in a way that put patients in serious jeopardy within the past three years, a KHN analysis finds.
Legislation would require minimum staffing levels, longer intervals between patients and more frequent state inspections.
The HHS inspector general’s office found that Medicare should have done an in-depth review of suspicious or aberrant infection reports from scores of hospitals.
After the medical board reinstated the license of doctor who molested patients, one member –now president — secured a $40 million donation for a pet project from the doctor’s relative. He says the two events are unrelated. Critics are demanding an investigation.
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
A new study examines how well efforts are working that prioritize the needs of these patients if they end up needing a kidney transplant of their own.
In a small study, Minnesota researchers found that the infant drops used to increase visibility during procedures may create a “perfect habitat” for bacteria and make scopes harder to clean.
U.S. Rep. Ted Lieu (D-Calif.) renews his call for tightened laws that would force manufacturers to notify the Food and Drug Administration when they issue safety warnings in other countries related to the design and cleaning of their devices.
Newly released court documents show that after Tokyo-based Olympus Corp. alerted customers in Europe in 2013, it told its U.S. operation not to warn U.S. doctors and hospitals. Since then, at least 35 patients have died after being sickened in outbreaks.
Overall rates are falling in California and nationally but data point to certain hospitals with extremely high percentages.
Thousands of patients at the San Diego-area hospital may have been exposed to infection last year because of unsanitary conditions in the compounding lab where IVs were mixed, officials found.